Research programme: gene therapeutics - Obsidian Therapeutics/Vertex Pharmaceuticals
Alternative Names: Gene therapeutics - Obsidian Therapeutics/Vertex PharmaceuticalsLatest Information Update: 05 May 2021
At a glance
- Originator Obsidian Therapeutics
- Class Gene therapies
- Mechanism of Action Gene transference
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Research Unspecified